3′,4′-dihydroxyl groups in luteolin are important for its inhibitory activities against ADAMTS-4

Bulletin of the Korean Chemical Society

Volumn 33, Issue 9, 2012, Pages 2907-2908

  Choi, Jiwon ^a   Jeong, Ki Woong ^b   Kim, Jin Kyoung ^b   Chang, Byungha ^a   Lee, Jee Young ^a,b   Kim, Yangmee ^b  

^a Bioinformatics and Molecular Design Research Center (BMDRC)   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

ADAMTS 4; Docking; Flavonoid; Luteolin; Metalloprotease

Indexed keywords

ADAMTS-4; BINDING MODELS; FLAVONOID; INHIBITORY ACTIVITY; LUTEOLIN; METALLO-PROTEASE; MOLECULAR BASIS; POTENT INHIBITOR; THERAPEUTIC TARGETS; THROMBOSPONDIN; VON WILLEBRAND FACTOR;

DOCKING; HYDROGEN BONDS;

GLYCOPROTEINS;

EID: 84866386312     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2012.33.9.2907     Document Type: Article

References (20)

1. Le, Goff C.; Cormier-Daire, V. Hum. Mol. Genet. 2011, 20, R163-R167.
2. Porter, S.; Clark, I. M.; Kevorkian, L.; Edwards, D. R. Biochem. J. 2005, 386, 15-27.
3. Stanton, H.; Melrose, J.; Little, C. B.; Fosang, A. J. Biochim. Biophys. Acta 2011, 1812, 1616-1629.
4. Verma, P.; Dalal, K. J. Cell Biochem. 2011, 112, 3507-3514.
5. Okada, A.; Okada, Y. Clin. Calcium. 2009, 19, 1593-1601.
6. Apte, S. S. J. Biol. Chem. 2009, 284, 31493-31497.
7. Nicholson, A. C.; Malik, S. B.; Logsdon, J. M., Jr.; Van Meir, E. G. BMC Evol. Biol. 2005, 4, 11.
8. Hashimoto, G.; Shimoda, M.; Okada, Y. J. Biol. Chem. 2004, 279, 32483-32491.
9. Groma, G.; Grskovic, I.; Schael, S.; Ehlen, H. W.; Wagener, R.; Fosang, A.; Aszodi, A.; Paulsson, M.; Brachvogel, B.; Zaucke, F. Matrix Biol. 2011, 30, 275-280.
10. Moncada-Pazos, A.; Obaya, A. J.; Viloria, C. G.; López- Otín, C.; Cal, S. J. Mol. Med (Berl). 2011, 89, 611-619.
11. Cazarolli, L. H.; Zanatta, L.; Alberton, E. H.; Figueiredo, M. S.; Folador, P.; Damazio, R. G.; Pizzolatti, M. G.; Silva, F. R. Mini Rev. Med. Chem. 2008, 8, 1429-1440.
12. Rajnaryana, K.; Sripalreddy, M.; Chalavadi, M. R.; Krishna, D. R. Indian J. Pharmacol. 2001, 33, 2-16.
13. Jang, S.; Kelley, K. W.; Johnson, R. W. Proc. Natl. Acad. Sci. USA. 2008, 105, 7534-7539.
14. Yu, M. C.; Chen, J. H.; Lai, C. Y.; Han, C. Y.; Ko, W. C. Eur. J. Pharmacol. 2010, 627, 269-275.
15. Wu, G.; Robertson, D. H.; Brooks, C. L., III.; Vieth, M. A. J. Comput. Chem. 2003, 24, 1549-1562.
16. Vieth, M.; Hirst, J. D.; Kolinski, A.; Brooks, C. L. J. Comput. Chem. 1998, 19, 1612-1622.
17. Vieth, M.; Hirst, J. D.; Dominy, B. N.; Daigler, H.; Brooks, C. L. J. Comput. Chem. 1998, 19, 1623-1631.
18. Mosyak, L.; Georgiadis, K.; Shane, T.; Svenson, K.; Hebert, T.; McDonagh, T.; Mackie, S.; Olland, S.; Lin, L.; Zhong, X.; Kriz, R.; Reifenberg, E. L.; Collins-Racie, L. A.; Corcoran, C.; Freeman, B.; Zollner, R.; Marvell, T.; Vera, M.; Sum, P. E.; Lavallie, E. R.; Stahl, M.; Somers, W. Protein Sci. 2008, 17, 16-21.
19. Malešev, D.; Kuntiæ, V. J. Serb. Chem. Soc. 2007, 72, 921-939.
20. Dowling, S.; Regan, F.; Hughes, H. J. Inorg. Biochem. 2010, 104, 1091-1098.